Stockscreener 앱 받기
50.52
2.88%
1.445
Novo Nordisk Adr 주식(NVO)의 최신 뉴스
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market? - The Motley Fool
NVO Stock Quote Price and Forecast - CNN
Novo Nordisk A/Sshare repurchase programme - Finansavisen
Novo Nordisk (NYSE:NVO) Updates Wegovy Label In Singapore With 21% Weight Loss Data - Sahm
Total equity of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOD - TradingView
Weekly Recap: NOVO_B MAR buyback and Shares jump after UK Wegovy approval - TradingView
Novo Nordisk (NVO) Wins UK Wegovy Pill Approval As Medicare Opens GLP 1 Access - Sahm
NVONovo Nordisk ADR Options - Finviz
Market news - investments.halifax.co.uk
European ADRs Slid In US Trading On Wednesday - Finimize
Novo Nordisk holds analyst rating, JPMorgan reiterates Neutral on the shares - Ad-hoc-news.de
Novo Nordisk consensus picture, shares backed by strong obesity demand - Ad-hoc-news.de
NOVA Forecast — Price Target — Prediction for 2027 - TradingView
NVO Forecast — Price Target — Prediction for 2027 - TradingView
Novo Nordisk consensus shifts after analyst moves, shares trade lower in Europe - AD HOC NEWS
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B - TradingView
Novo Nordisk consensus after Morningstar downgrade, shares remain in focus on NYSE and Copenhagen - Ad-hoc-news.de
NVO/N Forecast — Price Target — Prediction for 2027 - TradingView
Non-controlling/minority interest of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView
Novo Nordisk (NYSE: NVO) repurchases 20,959,179 shares in 2026 - Stock Titan
Novo Nordisk updates analyst targets, shares stay in S&P 500 focus - AD HOC NEWS
Novo Nordisk Stock Is Surging Monday: What's Driving The Action? - Sahm
Novo Nordisk wins key South Africa ruling, shares extend obesity-drug lead - Ad-hoc-news.de
Wegovy from Novo Nordisk A/ S (ADR)weekly injection reshapes obesity care - AD HOC NEWS
European ADRs Open The Week Higher In US Trading - Finimize
Novo Nordisk StockAnalyst consensus and GLP-1 momentum - AD HOC NEWS
Novo Nordisk (NYSE:NVO) Faces Cyber Breach While Pushing Oral Wegovy Into China - Sahm
Why Novo Nordisk’s Wegovy weekly injection changes daily routines - AD HOC NEWS
1.14%
자본화:
|
볼륨(24시간):